A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma-Reference-Cited by-同舟云学术

A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma

Published:2014-06-02 Issue:1 Volume:2 Page:
ISSN:2051-5960
Container-title:Acta Neuropathologica Communications
language:en
Short-container-title:acta neuropathol commun

Author:

Catteau Aurélie,Girardi Hélène,Monville Florence,Poggionovo Cécile,Carpentier Sabrina,Frayssinet Véronique,Voss Jesse,Jenkins Robert,Boisselier Blandine,Mokhtari Karima,Sanson Marc,Peyro-Saint-Paul Hélène,Giannini Caterina

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/2051-5960-2-58.pdf

Reference38 articles.

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007, 114(2):97–109. doi:10.1007/s00401–007–0243–4 10.1007/s00401-007-0243-4

2. Weller M, Pfister SM, Wick W, Hegi ME, Reifenberger G, Stupp R: Molecular neuro-oncology in clinical practice: a new horizon. Lancet Oncol 2013, 14(9):e370-e379. doi:10.1016/S1470–2045(13)70168–2 10.1016/S1470-2045(13)70168-2

3. Thomas L, Di Stefano AL, Ducray F: Predictive biomarkers in adult gliomas: the present and the future. Curr Opin Oncol 2013, 25(6):689–694. doi:10.1097/CCO.0000000000000002 10.1097/CCO.0000000000000002

4. Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken JW, Wesseling P, Reifenberger G, von Deimling A: Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol 2009, 118(4):469–474. doi:10.1007/s00401–009–0561–9 10.1007/s00401-009-0561-9

5. von Deimling A, Korshunov A, Hartmann C: The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations. Brain Pathol 2011, 21(1):74–87. doi:10.1111/j.1750–3639.2010.00454.x 10.1111/j.1750-3639.2010.00454.x

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive clinical assays for molecular diagnostics of gliomas: the current state and future prospects;Frontiers in Molecular Biosciences;2023-10-16

2. Characterization of an IDH1 R132H Rabbit Monoclonal Antibody, MRQ-67, and Its Applications in the Identification of Diffuse Gliomas;Antibodies;2023-02-06

3. Clinical Evaluation of IDH Mutation Status in Formalin-Fixed Paraffin-Embedded Tissue in Gliomas;Molecular Diagnosis & Therapy;2023-01-23

4. Use of next-generation sequencing in daily routine practice;ONCOL CLIN PRACT;2023

5. Utility of Single-Gene Testing in Cancer Specimens;Clinics in Laboratory Medicine;2022-09